Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

3
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (0)

Searched Name

P. Blahovcová

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Sýkorová A, Pytlík R, Móciková H, Janíková A, Procházka V, Belada D, Šálek D, Benešová K, Klener P, Ďuraš J, Smolej L, Šimkovič M, Campr V, Vosáhlová V, Blahovcová P, Trněný M. Burkitt lymphoma-multicenter retrospective data analysis from the Czech Lymphoma Study Group-NiHiL project. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_90] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]

Affiliation(s)

A. Sýkorová 4th Department of Internal Medicine-Hematology; University Hospital and Faculty of Medicine; Hradec Kralove Czech Republic
R. Pytlík 1st Department of Medicine-Department of Hematology; Charles University, General Hospital; Prague Czech Republic
H. Móciková Department of Clinical Hematology; University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University; Prague Czech Republic
A. Janíková Department of Hematology and Oncology; University Hospital; Brno Czech Republic
V. Procházka Department of Hemato-Oncology, Faculty of Medicine and Dentistry; Palacky University; Olomouc Czech Republic
D. Belada 4th Department of Internal Medicine-Hematology; University Hospital and Faculty of Medicine; Hradec Kralove Czech Republic
D. Šálek Department of Hematology and Oncology; University Hospital; Brno Czech Republic
K. Benešová 1st Department of Medicine-Department of Hematology; Charles University, General Hospital; Prague Czech Republic
P. Klener 1st Department of Medicine-Department of Hematology; Charles University, General Hospital; Prague Czech Republic
J. Ďuraš Department of Hemato-Oncology; Faculty of Medicine; Ostrava Czech Republic
L. Smolej 4th Department of Internal Medicine-Hematology; University Hospital and Faculty of Medicine; Hradec Kralove Czech Republic
M. Šimkovič 4th Department of Internal Medicine-Hematology; University Hospital and Faculty of Medicine; Hradec Kralove Czech Republic
V. Campr Institute of Pathology; University Hospital Motol; Prague Czech Republic
V. Vosáhlová 4th Department of Internal Medicine-Hematology; University Hospital and Faculty of Medicine; Hradec Kralove Czech Republic
P. Blahovcová Data Management Office, 1st Department of Medicine-Department of Hematology; Charles University, General Hospital; Prague Czech Republic
M. Trněný 1st Department of Medicine-Department of Hematology; Charles University, General Hospital; Prague Czech Republic

Collapse

Klener P, Fronkova E, Belada D, Forsterova K, Pytlik R, Kalinova M, Simkovic M, Salek D, Mocikova H, Prochazka V, Blahovcová P, Janikova A, Markova J, Obr A, Berkova A, Vaskova M, Mejstrikova E, Campr V, Kubinyi J, Jaksa R, Kodet R, Michalova K, Trka J, Trneny M. R-CHOP/R-HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_68] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]

Affiliation(s)

P. Klener First Dept. of Internal Medicine; Charles University General Hospital in Prague; Prague 2 Czech Republic
E. Fronkova CLIP, Dept. of Pediatric Hematology/Oncology; Second Faculty of Medicine and University Hospital Motol Prague; Prague Czech Republic
D. Belada Fourth Dept. of Internal Medicine-Hematology; Charles University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove; Hradec Kralove Czech Republic
K. Forsterova First Dept. of Internal Medicine; Charles University General Hospital in Prague; Prague 2 Czech Republic
R. Pytlik First Dept. of Internal Medicine; Charles University General Hospital in Prague; Prague 2 Czech Republic
M. Kalinova Institute of Pathology and Molecular Medicine; Charles University Hospital in Motol and Second Faculty of Medicine, Prague; Prague Czech Republic
M. Simkovic Fourth Dept. of Internal Medicine-Hematology; Charles University Hospital Hradec Kralove and Faculty of Medicine in Hradec Kralove; Hradec Kralove Czech Republic
D. Salek Dept. of Hematology and Oncology; Masaryk University Hospital in Brno; Brno Czech Republic
H. Mocikova Dept. of Internal Medicine and Haematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine; Charles University, Prague; Prague Czech Republic
V. Prochazka Dept. of Hemato-Oncology, Faculty of Medicine and Dentistry; Palacky University and University Hospital Olomouc; Olomouc Czech Republic
P. Blahovcová First Dept. of Internal Medicine; Charles University General Hospital in Prague; Prague 2 Czech Republic
A. Janikova Dept. of Hematology and Oncology; Masaryk University Hospital in Brno; Brno Czech Republic
J. Markova Dept. of Internal Medicine and Haematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine; Charles University, Prague; Prague Czech Republic
A. Obr Dept. of Hemato-Oncology, Faculty of Medicine and Dentistry; Palacky University and University Hospital Olomouc; Olomouc Czech Republic
A. Berkova Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine; Charles University, Prague; Prague Czech Republic
M. Vaskova CLIP, Dept. of Pediatric Hematology/Oncology; Second Faculty of Medicine and University Hospital Motol Prague; Prague Czech Republic
E. Mejstrikova CLIP, Dept. of Pediatric Hematology/Oncology; Second Faculty of Medicine and University Hospital Motol Prague; Prague Czech Republic
V. Campr Institute of Pathology and Molecular Medicine; Charles University Hospital in Motol and Second Faculty of Medicine, Prague; Prague Czech Republic
J. Kubinyi Institute of nuclear medicine; Charles University General Hospital in Prague; Prague Czech Republic
R. Jaksa Institute of Pathology; Charles University Hospital and First Faculty of Medicine, Prague; Prague Czech Republic
R. Kodet Institute of Pathology and Molecular Medicine; Charles University Hospital in Motol and Second Faculty of Medicine, Prague; Prague Czech Republic
K. Michalova Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine; Charles University, Prague; Prague Czech Republic
J. Trka CLIP, Dept. of Pediatric Hematology/Oncology; Second Faculty of Medicine and University Hospital Motol Prague; Prague Czech Republic
M. Trneny First Dept. of Internal Medicine; Charles University General Hospital in Prague; Prague 2 Czech Republic

Collapse

Pytlík R, Heissigerová J, Karolová J, Klimová A, Svozílková P, Brichová M, Říhová E, Mrázová K, Špička I, Blahovcová P, Trněný M. Characteristics and natural history of primary vitreoretinal lymphoma (PVL) compared to the primary lymphoma of the CNS (PCNSL). Hematol Oncol 2017. [DOI: 10.1002/hon.2439_105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]